Procter & Gamble (PG) CFO exercises 33,624 options at $91.07 and sells shares at $165.
Procter & Gamble (PG) CFO exercises 33,624 options at $91.07 and sells shares at $165. Stock Titan
Covered in this story
Analyst targets on Procter & Gamble
- UBS: $159 → $172 by Oct 2027 · Buy via GuruFocus
- RBC Capital Markets: $148 → $166 by Oct 2027 via MarketBeat
- Evercore ISI: $150 → $166 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Procter & Gamble →Also covered by 1 other outlet
Dalsna Finance is currently tracking 48 stories mentioning Procter & Gamble, the earliest published 30 Jun 2026.
Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.